RSS-Feed abonnieren
DOI: 10.1055/s-0045-1811718
Endovascular Management of Pediatric Deep Venous Thrombosis
Authors

Abstract
This study aims to review current practices in thrombolysis and thrombectomy for managing deep venous thrombosis (DVT) and associated complications in the pediatric population. Pediatric thrombosis care has a rich history of evolution, from the early days of anticoagulation to the current era of endovascular therapies. This evolution has been driven by the need for a nuanced, multidisciplinary approach that includes interventional radiology (IR) and hematology. While anticoagulation remains the standard of care, endovascular therapies are increasingly utilized in cases of extensive, occlusive, or limb-threatening DVT, particularly to prevent pulmonary embolism and postthrombotic syndrome (PTS) and to preserve venous patency. This review outlines the indications, contraindications, and procedural techniques for catheter-directed thrombolysis, pharmaco-mechanical thrombectomy (PMT), mechanical thrombectomy, and venous stenting in children. It emphasizes the crucial role of a multidisciplinary team, including pediatric hematologists, interventional radiologists, and other medical professionals, in managing pediatric DVT. This collaboration is essential for considering pediatric-specific factors such as patient size, sedation requirements, radiation, contrast dosing, and anticoagulation. Also highlighted are postprocedural care, anticoagulation strategies, and imaging follow-up. Multidisciplinary collaboration is critical to improving outcomes for children with thrombotic disease.
Publikationsverlauf
Artikel online veröffentlicht:
25. September 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Monagle P, Cuello CA, Augustine C. et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2018; 2 (22) 3292-3316
- 2 Goldenberg NA, Schulman S, Kittelson JM. et al; Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) Trial Investigators and the Antithrombotic Trials Leadership and Steering (ATLAS) Group. Duration of anticoagulation for venous thromboembolism in pediatric patients: evaluation of the duration of therapy for thrombosis in children (Kids-DOTT) trial outcomes at 2 years. J Thromb Haemost 2025; 23 (02) 651-656
- 3 Shoag J, Davis JA, Corrales-Medina FF. Venous thromboembolism in pediatrics. Pediatr Rev 2021; 42 (02) 78-89
- 4 Raffini L, Huang Y-S, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics 2009; 124 (04) 1001-1008
- 5 Jaffray J, Young G. Deep vein thrombosis in pediatric patients. Pediatr Blood Cancer 2018; 65 (03)
- 6 Jaffray J, Bauman M, Massicotte P. The impact of central venous catheters on pediatric venous thromboembolism. Front Pediatr 2017; 5: 5
- 7 Gill AE, Patel KN. The role of interventional radiology in the treatment of acute thrombosis and chronic veno-occlusive disease in children and adolescents. Semin Roentgenol 2019; 54 (04) 324-336
- 8 Tarango C, Manco-Johnson MJ. Pediatric thrombolysis: a practical approach. Front Pediatr 2017; 5: 260
- 9 Bertino FJ, Hawkins CM, Woods GM. et al. Technical feasibility and clinical efficacy of iliac vein stent placement in adolescents and young adults with May-Thurner syndrome. Cardiovasc Intervent Radiol 2024; 47 (01) 45-59
- 10 Dandoy CE, Kukreja KU, Gruppo RA, Patel MN, Tarango C. Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis. Pediatr Radiol 2015; 45 (05) 719-726
- 11 Goldman RE, Arendt VA, Kothary N. et al. Endovascular management of May-Thurner syndrome in adolescents: a single-center experience. J Vasc Interv Radiol 2017; 28 (01) 71-77
- 12 Gaballah M, Shi J, Kukreja K. et al. Endovascular thrombolysis in the management of iliofemoral thrombosis in children: a multi-institutional experience. J Vasc Interv Radiol 2016; 27 (04) 524-530
- 13 Annam A, Rochon P, Thornhill D. et al. 03:18 PM Abstract No. 45 Prospective comparison of pharmacomechanical thrombolysis versus anticoagulation for treatment of pediatric iliofemoral deep venous thrombosis: 2-year follow up. J Vasc Interv Radiol 2019; 30: S23
- 14 Kukreja KU, Lungren MP, Patel MN. et al. Endovascular venous thrombolysis in children younger than 24 months. J Vasc Interv Radiol 2014; 25 (08) 1158-1164
- 15 Karim S, Gayou E, Gross J. et al. Selective iliofemoral stent placement for complex pediatric cases: a decade of institutional experience. Pediatr Radiol 2024; 54 (09) 1540-1548
- 16 Warad DM, Rao AN, Bjarnason H, Rodriguez V. Clinical outcomes of May-Thurner syndrome in pediatric patients: a single institutional experience. TH Open 2020; 4 (03) e189-e196
- 17 Monagle P, Chan AKC, Goldenberg NA. et al. (2012) Antithrombotic Therapy in Neonates and Children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 141:e737S-e801S. https://doi.org/10.1378/chest.11-2308
- 18 Goldenberg NA, Kittelson JM, Abshire TC. et al; Kids-DOTT Trial Investigators and the ATLAS Group. Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the kids-DOTT randomized clinical trial. JAMA 2022; 327 (02) 129-137
- 19 Goldfisher R. Lower-extremity venous ultrasound - past, present and future. Pediatr Radiol 2017; 47 (09) 1209-1213
- 20 Pulmonary Embolism or Deep Vein Thrombosis Diagnosis and Treatment/Management | Children's Hospital Colorado. Accessed April 20, 2025 at: https://www.childrenscolorado.org/healthprofessionals/clinical-resources/clinical-pathways/vte-clinical-pathway/
- 21 Krishnaswamy A, Lincoff AM, Cannon CP. The use and limitations of unfractionated heparin. Crit Pathw Cardiol 2010; 9 (01) 35-40
- 22 Buck ML. Bivalirudin as an alternative to heparin for anticoagulation in infants and children. J Pediatr Pharmacol Ther 2015; 20 (06) 408-417
- 23 Young VA, Thakor AS, Josephs SC. Update on pediatric interventional radiology. Radiographics 2022; 42 (06) 1580-1597
- 24 Shammas NW. Bivalirudin: pharmacology and clinical applications. Cardiovasc Drug Rev 2005; 23 (04) 345-360
- 25 Zuily S, Cohen H, Isenberg D. et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2020; 18 (09) 2126-2137
- 26 Herzog E, Zavaletta V, Katz D. et al. Interventional treatment of pediatric venous thromboembolic disease. Tech Vasc Interv Radiol 2024; 27 (02) 100957
- 27 Manco-Johnson MJ. How I treat venous thrombosis in children. Blood 2006; 107 (01) 21-29
- 28 Marlar RA, Gausman JN. Laboratory testing issues for protein C, protein S, and antithrombin. Int J Lab Hematol 2014; 36 (03) 289-295
- 29 Hansrani V, Moughal S, Elmetwally A, Al-Khaffaf H. A review into the management of May-Thurner syndrome in adolescents. J Vasc Surg Venous Lymphat Disord 2020; 8 (06) 1104-1110
- 30 Goldenberg NA, Brandão L, Journeycake J. et al; Perinatal And Paediatric Haemostasis Subcommittee Of The Scientific And Standardization Committee Of The International Society On Thrombosis And Haemostasis. Definition of post-thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations. J Thromb Haemost 2012; 10 (03) 477-480
- 31 Goldenberg NA, Donadini MP, Kahn SR. et al. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica 2010; 95 (11) 1952-1959
- 32 Avila L, Amiri N, De R. et al. Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children. Blood Adv 2021; 5 (19) 3737-3747
- 33 Betensky M, Goldenberg NA. Post-thrombotic syndrome in children. Thromb Res 2018; 164: 129-135
- 34 Dukkipati R, Yang EH, Adler S, Vintch J. Acute kidney injury caused by intravascular hemolysis after mechanical thrombectomy. Nat Clin Pract Nephrol 2009; 5 (02) 112-116
- 35 Harvey JJ, Hopkins J, McCafferty IJ, Jones RG. Inferior vena cava filters: what radiologists need to know. Clin Radiol 2013; 68 (07) 721-732
- 36 Plotnik AN, Haber Z, Kee S. Early thrombus removal for acute lower extremity deep vein thrombosis: update on inclusion, technical aspects, and postprocedural management. Cardiovasc Intervent Radiol 2024; 47 (12) 1595-1604
- 37 Hanslik A, Kitzmüller E, Tran US. et al. Monitoring unfractionated heparin in children: a parallel-cohort randomized controlled trial comparing 2 dose protocols. Blood 2015; 126 (18) 2091-2097
- 38 Bhatt MD, Paes BA, Chan AK. How to use unfractionated heparin to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis 2016; 27 (06) 605-614
- 39 Sidhu M, Strauss KJ, Connolly B. et al. Radiation safety in pediatric interventional radiology. Tech Vasc Interv Radiol 2010; 13 (03) 158-166
- 40 Mahesh M. Radiation dose management for fluoroscopically guided interventional medical procedures. Med Phys 2012; 39: 5789-5790
- 41 Fisher RF, Applegate KE, Berkowitz LK. et al. AAPM medical physics practice guideline 12.a: fluoroscopy dose management. J Appl Clin Med Phys 2022; 23 (03) e13526
- 42 American Association of Physicists in Medicine. (2019) AAPM PS8-A: AAPM Position Statement on the Use of Patient Gonadal and Fetal Shielding. Accessed April 27, 2025 at: https://www.aapm.org/org/policies/details.asp?id=2552
- 43 Marsh RM, Silosky M. Patient shielding in diagnostic imaging: discontinuing a legacy practice. AJR Am J Roentgenol 2019; 212 (04) 755-757
- 44 Balter S, Hopewell JW, Miller DL, Wagner LK, Zelefsky MJ. Fluoroscopically guided interventional procedures: a review of radiation effects on patients' skin and hair. Radiology 2010; 254 (02) 326-341
- 45 Greene LA, Goldenberg NA. Deep vein thrombosis: thrombolysis in the pediatric population. Semin Intervent Radiol 2012; 29 (01) 36-43
- 46 Boston Scientific Corp. (2025) AngioJet Thrombectomy System. In: AngioJet Thrombectomy Syst. Accessed September 1, 2025 at: https://www.bostonscientific.com/en-US/products/thrombectomysystems/angiojet-thrombectomy-system.html
- 47 Inari MEdical. (2025) ClotTriever Thrombectomy System. In: ClotTriever Thrombectomy Syst. Accessed September 1, 2025 at: https://www.inarimedical.com/clottriever-system
- 48 Penumbra, Inc. (2025) Indigo Aspiration System. In: Indigo Aspiration Syst. Accessed September 1, 2025 at: https://www.penumbrainc.com/products/peripheral-thrombectomy-indigo-system/
- 49 Alvi AA. Penumbra's Indigo System With Lightning Intelligent Aspiration -Endovascular Today. In: Endovasc. Today. Accessed April 27, 2025 at: https://evtoday.com/articles/2022-july/penumbras-indigo-system-with-lightning-intelligentaspiration?utm_source=chatgpt.com
- 50 Monroe EJ, Woods MA, Shin DS. et al. Percutaneous treatment of symptomatic deep vein thrombosis in adolescents using large-bore thrombectomy systems. Pediatr Radiol 2023; 53 (13) 2692-2698
- 51 Philips. (2025) Peripheral Intravascular Ultrasound (IVUS). Accessed September 1, 2025 at: https://www.usa.philips.com/healthcare/technology/peripheral-intravascular-ultrasound
- 52 Luijkx T, Knipe H. et al. Risser staging system | Radiology Reference Article | Radiopaedia.org. In: Risser Staging Syst. Accessed April 27, 2025 at: https://radiopaedia.org/articles/risser-stagingsystem? lang=us
- 53 Kishore S, Khaja MS, Thornburg B. et al. Antithrombotic therapy after venous interventions: AJR expert panel narrative review. AJR Am J Roentgenol 2022; 219 (02) 175-187
- 54 Clode H, Spencer EB, Nelson J, Horne ES. Efficacy of ultrasound in the evaluation of iliac vein stenting. Phlebology 2025; 40 (02) 110-115